<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0017">
 <label>17</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Machado</surname>
    <given-names>VA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Peixoto</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Costa</surname>
    <given-names>R</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Synthesis, antiangiogenesis evaluation and molecular docking studies of 1-aryl-3-[(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas: discovery of a new substitution pattern for type II VEGFR-2 Tyr kinase inhibitors</article-title>. 
  <source>Bioorg Med Chem</source>
  <year>2015</year>;
  <volume>23</volume>:
  <fpage>6497</fpage>–
  <lpage>509</lpage>.
  <pub-id pub-id-type="pmid">26344591</pub-id>
 </mixed-citation>
</ref>
